Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Translating the Immunogenicity of Prime-boost Immunization With ChAd63 and MVA ME-TRAP From Malaria Naive to Malaria-endemic Populations
Domtila Kimani, Ya Jankey Jagne, Momodou Cox, et al.
Molecular Therapy (2014) Vol. 22, Iss. 11, pp. 1992-2003
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
Katie Ewer, Tommy Rampling, Navin Venkatraman, et al.
New England Journal of Medicine (2015) Vol. 374, Iss. 17, pp. 1635-1646
Open Access | Times Cited: 346
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
Katharine A. Collins, Rebecca Snaith, Matthew G. Cottingham, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 210
High-throughput single-сell sequencing in cancer research
Qingzhu Jia, Han Chu, Jin Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 92
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
Ruth Payne, Sarah E. Silk, Sean C. Elias, et al.
JCI Insight (2017) Vol. 2, Iss. 21
Open Access | Times Cited: 133
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults
Caroline Ogwang, Domtila Kimani, Nick J. Edwards, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 286
Open Access | Times Cited: 128
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01BWith Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
Tommy Rampling, Katie Ewer, Georgina Bowyer, et al.
The Journal of Infectious Diseases (2016) Vol. 214, Iss. 5, pp. 772-781
Open Access | Times Cited: 89
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
Sarah E. Silk, Wilmina F. Kalinga, Ivanny M. Mtaka, et al.
Med (2023) Vol. 4, Iss. 10, pp. 668-686.e7
Open Access | Times Cited: 27
Assessment of Humoral Immune Responses to Blood-Stage Malaria Antigens following ChAd63-MVA Immunization, Controlled Human Malaria Infection and Natural Exposure
Sumi Biswas, Prateek Choudhary, Sean C. Elias, et al.
PLoS ONE (2014) Vol. 9, Iss. 9, pp. e107903-e107903
Open Access | Times Cited: 65
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
Muhammed O. Afolabi, Alfred B. Tiono, Uche J. Adetifa, et al.
Molecular Therapy (2016) Vol. 24, Iss. 8, pp. 1470-1477
Open Access | Times Cited: 59
Vector-based genetically modified vaccines: Exploiting Jenner’s legacy
Bahar Ramezanpour, Ingrid Haan, Ab Osterhaus, et al.
Vaccine (2016) Vol. 34, Iss. 50, pp. 6436-6448
Open Access | Times Cited: 57
Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
Katie Ewer, Kailan Sierra-Davidson, Ahmed M. Salman, et al.
Vaccine (2015) Vol. 33, Iss. 52, pp. 7444-7451
Open Access | Times Cited: 56
Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal
Victorine A. Mensah, Aly Gueye, Magatte Ndiaye, et al.
PLoS ONE (2016) Vol. 11, Iss. 12, pp. e0167951-e0167951
Open Access | Times Cited: 48
Adenoviral vaccines—Infectious disease
Carly M. Bliss, Gerardo Montalvo Zurbia-Flores, Daniel Wright, et al.
Elsevier eBooks (2025), pp. 573-642
Closed Access
Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy
Tom Ford, Claire Wenden, Alison Mbekeani, et al.
Vaccine (2017) Vol. 35, Iss. 15, pp. 1898-1906
Open Access | Times Cited: 44
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants
Carly M. Bliss, Abdoulie Drammeh, Georgina Bowyer, et al.
Molecular Therapy (2017) Vol. 25, Iss. 2, pp. 547-559
Open Access | Times Cited: 42
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
Carly M. Bliss, Georgina Bowyer, Nicholas Anagnostou, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 41
Effects of cryopreservation on chimeric antigen receptor T cell functions
Hao Xu, Wenyue Cao, Liang Huang, et al.
Cryobiology (2018) Vol. 83, pp. 40-47
Closed Access | Times Cited: 40
Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge
Scott G. Hansen, Jennie Womack, Isabel Scholz, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210252-e0210252
Open Access | Times Cited: 38
Pre-Erythrocytic Vaccines against Malaria
Camila Marques-da-Silva, Kristen Peissig, Samarchith P. Kurup
Vaccines (2020) Vol. 8, Iss. 3, pp. 400-400
Open Access | Times Cited: 34
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial
Hans de Graaf, Ruth Payne, Iona J. Taylor, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
A systematic review on malaria and Tuberculosis (TB) vaccine challenges in sub-Saharan African clinical trials
Maonezi Abas Hamisi, Nur Atikah Mohd Asri, Aini Syahida Mat Yassim, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317233-e0317233
Open Access
Recent Developments in Malaria Vaccinology
Benedict R. Halbroth, Simon J. Draper
Advances in Parasitology/Advances in parasitology (2015), pp. 1-49
Closed Access | Times Cited: 40
CXCR3+ T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria
Georgina Bowyer, Amy Grobbelaar, Tommy Rampling, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 37
Malaria vaccines in the eradication era: current status and future perspectives
Kirsty Wilson, Katie L. Flanagan, Monica D. Prakash, et al.
Expert Review of Vaccines (2019) Vol. 18, Iss. 2, pp. 133-151
Closed Access | Times Cited: 35
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
Gustavo Cabral‐Miranda, Matthew D. Heath, Mona O. Mohsen, et al.
Vaccines (2017) Vol. 5, Iss. 2, pp. 10-10
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top